• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体基因多态性与雄激素性脱发风险:荟萃分析。

Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.

机构信息

Department of Dermatology, Beijing Friendship hospital, Capital Medical University, Beijing, China.

出版信息

Clin Exp Dermatol. 2012 Mar;37(2):104-11. doi: 10.1111/j.1365-2230.2011.04186.x. Epub 2011 Oct 10.

DOI:10.1111/j.1365-2230.2011.04186.x
PMID:21981665
Abstract

BACKGROUND

Numerous studies have shown an association between polymorphisms in the androgen receptor gene (AR) and the risk for androgenetic alopecia (AGA), but the overall results are still controversial.

AIM

To determine, by conducting a meta-analysis, whether the common AR gene polymorphisms confer susceptibility to AGA.

METHODS

Publications addressing the association between AR gene polymorphisms and risk for AGA were selected from the PubMed, EMBASE and CBMdisc databases. Data were extracted from the studies by two independent reviewers. The meta-analysis was performed using the software programs RevMan (version 5.0.25) and STATA (version 9.2). From these data, odds ratio (OR) with 95% confidence interval (CI) was calculated.

RESULTS

Only eight studies were found, reporting a total of 2074 patients with AGA and 1115 healthy controls. Three common polymorphisms of the AR gene were addressed: a StuI restriction-site polymorphism (rs6152, G>A), and CAG and GGC triplet-repeat polymorphisms. Meta-analysis results identified a significant association between the G allele of the AR StuI polymorphism and the risk for AGA (OR = 2.68, 95% CI 1.71-4.19, P < 0.01), especially in white populations (OR = 2.76, 95% CI 1.71-4.45, P < 0.01). No association was found between the CAG or GGC polymorphism and the risk for AGA (OR = 0.81, 95% CI 0.49-1.34, P = 0.41; OR = 1.01, 95% CI 0.47-2.14, P = 0.99, respectively).

CONCLUSION

Our meta-analysis suggests that the G allele of AR StuI polymorphism might be a potential risk factor for AGA, especially in white populations. However, we did not find any obvious association of the CAG and GGC triplet-repeat polymorphisms of the AR gene with risk for AGA.

摘要

背景

大量研究表明,雄激素受体(AR)基因多态性与雄激素性脱发(AGA)的风险之间存在关联,但总体结果仍存在争议。

目的

通过荟萃分析确定常见的 AR 基因多态性是否与 AGA 的易感性相关。

方法

从 PubMed、EMBASE 和 CBMdisc 数据库中选择了探讨 AR 基因多态性与 AGA 风险之间关系的出版物。由两名独立的审查员从研究中提取数据。使用 RevMan(版本 5.0.25)和 STATA(版本 9.2)软件程序进行荟萃分析。从这些数据中计算了比值比(OR)及其 95%置信区间(CI)。

结果

仅发现八项研究,共纳入 2074 例 AGA 患者和 1115 例健康对照者。分析了 AR 基因的三个常见多态性:StuI 限制性内切酶多态性(rs6152,G>A)以及 CAG 和 GGC 三核苷酸重复多态性。荟萃分析结果表明,AR StuI 多态性的 G 等位基因与 AGA 的风险之间存在显著关联(OR=2.68,95%CI 1.71-4.19,P<0.01),尤其是在白种人群中(OR=2.76,95%CI 1.71-4.45,P<0.01)。CAG 或 GGC 多态性与 AGA 的风险之间没有关联(OR=0.81,95%CI 0.49-1.34,P=0.41;OR=1.01,95%CI 0.47-2.14,P=0.99)。

结论

本荟萃分析表明,AR StuI 多态性的 G 等位基因可能是 AGA 的潜在危险因素,尤其是在白种人群中。然而,我们没有发现 AR 基因的 CAG 和 GGC 三核苷酸重复多态性与 AGA 风险之间存在明显关联。

相似文献

1
Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.雄激素受体基因多态性与雄激素性脱发风险:荟萃分析。
Clin Exp Dermatol. 2012 Mar;37(2):104-11. doi: 10.1111/j.1365-2230.2011.04186.x. Epub 2011 Oct 10.
2
Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia.雄激素受体基因作为女性雄激素性脱发候选基因的评估
Int J Dermatol. 2009 Jun;48(6):584-7. doi: 10.1111/j.1365-4632.2009.03991.x.
3
Men with Kennedy disease have a reduced risk of androgenetic alopecia.患有肯尼迪病的男性患雄激素性脱发的风险降低。
Br J Dermatol. 2007 Aug;157(2):290-4. doi: 10.1111/j.1365-2133.2007.08026.x. Epub 2007 Jun 26.
4
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.E211 G>A雄激素受体多态性与转移性前列腺癌和雄激素性脱发风险降低相关。
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):993-6. doi: 10.1158/1055-9965.EPI-04-0778.
5
Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.一项基于人群的年轻女性病例对照研究中雄激素受体(CAG)n和(GGC)n多态性与乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.
6
Lack of concordance and linkage disequilibrium among brothers for androgenetic alopecia and CAG/GGC haplotypes of the androgen receptor gene in Mexican families.墨西哥家庭中兄弟间雄激素性脱发与雄激素受体基因CAG/GGC单倍型之间缺乏一致性和连锁不平衡。
J Cosmet Dermatol. 2015 Dec;14(4):268-73. doi: 10.1111/jocd.12159. Epub 2015 Jul 14.
7
GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.子宫内膜癌患者雄激素受体基因上的GGC和StuI多态性
Biochem Biophys Res Commun. 2005 Apr 1;329(1):100-4. doi: 10.1016/j.bbrc.2005.01.104.
8
Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.p53基因密码子72多态性与子宫内膜癌风险增加相关性的Meta分析。
Genet Mol Res. 2011 Oct 31;10(4):3609-19. doi: 10.4238/2011.October.31.11.
9
Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia.雄激素性脱发女性额顶部毛囊中雄激素受体信使核糖核酸增加。
Genet Mol Res. 2013 Jun 11;12(2):1834-40. doi: 10.4238/2013.February.28.19.
10
[Association of male infertility with (CAG)n polymorphism of the androgen receptor gene: a meta-analysis].雄激素受体基因(CAG)n多态性与男性不育的关联:一项荟萃分析
Zhonghua Nan Ke Xue. 2009 Sep;15(9):809-13.

引用本文的文献

1
Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy.新型给药策略:负载非那雄胺的固体脂质纳米粒用于改善雄激素性脱发治疗
RSC Adv. 2025 Jun 4;15(23):18715-18731. doi: 10.1039/d5ra00399g. eCollection 2025 May 29.
2
Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia.雄激素性脱发发病机制中的免疫与非免疫相互作用
Clin Rev Allergy Immunol. 2025 Mar 1;68(1):22. doi: 10.1007/s12016-025-09034-5.
3
Androgenetic alopecia: An update.雄激素性脱发:最新进展。
JAAD Int. 2023 Jul 22;13:150-158. doi: 10.1016/j.jdin.2023.07.005. eCollection 2023 Dec.
4
Predicting Physical Appearance from DNA Data-Towards Genomic Solutions.从 DNA 数据预测身体外貌-迈向基因组解决方案。
Genes (Basel). 2022 Jan 10;13(1):121. doi: 10.3390/genes13010121.
5
Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men.血清雄激素相关激素水平与年轻男性雄激素性脱发的疗效相关。
Med Sci Monit. 2018 Oct 30;24:7770-7777. doi: 10.12659/MSM.913116.
6
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.瑞典男性中携带雄激素受体E213 A等位基因者患前列腺癌风险较低。
Cancer Causes Control. 2017 Mar;28(3):227-233. doi: 10.1007/s10552-017-0859-1. Epub 2017 Feb 7.
7
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia.雄激素受体(AR)基因(CAG)n和(GGN)n长度多态性与使用非那雄胺治疗雄激素性脱发后出现长期不良影响的年轻男性的症状
Sex Med. 2017 Mar;5(1):e61-e71. doi: 10.1016/j.esxm.2016.11.001. Epub 2016 Dec 23.
8
Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?2D:4D指长比是男性雄激素性脱发的一个指标吗?
An Bras Dermatol. 2016 Apr;91(2):156-9. doi: 10.1590/abd1806-4841.20164622.
9
Evaluation of DNA variants associated with androgenetic alopecia and their potential to predict male pattern baldness.与雄激素性脱发相关的DNA变异评估及其预测男性型秃发的潜力。
PLoS One. 2015 May 22;10(5):e0127852. doi: 10.1371/journal.pone.0127852. eCollection 2015.
10
Gender Specificity of a Genetic Variant of Androgen Receptor and Risk of Coronary Artery Disease.雄激素受体基因变异的性别特异性与冠状动脉疾病风险
J Clin Lab Anal. 2016 May;30(3):204-7. doi: 10.1002/jcla.21837. Epub 2015 Feb 25.